150 related articles for article (PubMed ID: 38828722)
21. TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial.
Svensson EC; Madar A; Campbell CD; He Y; Sultan M; Healey ML; Xu H; D'Aco K; Fernandez A; Wache-Mainier C; Libby P; Ridker PM; Beste MT; Basson CT
JAMA Cardiol; 2022 May; 7(5):521-528. PubMed ID: 35385050
[TBL] [Abstract][Full Text] [Related]
22. A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in Myeloid Neoplasms.
Guan Y; Tiwari AD; Phillips JG; Hasipek M; Grabowski DR; Pagliuca S; Gopal P; Kerr CM; Adema V; Radivoyevitch T; Parker Y; Lindner DJ; Meggendorfer M; Abazeed M; Sekeres MA; Mian OY; Haferlach T; Maciejewski JP; Jha BK
Blood Cancer Discov; 2021 Mar; 2(2):146-161. PubMed ID: 33681816
[No Abstract] [Full Text] [Related]
23. Clonality in haematopoietic stem cell ageing.
Terradas-Terradas M; Robertson NA; Chandra T; Kirschner K
Mech Ageing Dev; 2020 Jul; 189():111279. PubMed ID: 32526214
[TBL] [Abstract][Full Text] [Related]
24. TET-dioxygenase deficiency in oncogenesis and its targeting for tumor-selective therapeutics.
Guan Y; Hasipek M; Tiwari AD; Maciejewski JP; Jha BK
Semin Hematol; 2021 Jan; 58(1):27-34. PubMed ID: 33509440
[TBL] [Abstract][Full Text] [Related]
25. DNA methyltransferase 3 alpha and TET methylcytosine dioxygenase 2 restrain mitochondrial DNA-mediated interferon signaling in macrophages.
Cobo I; Tanaka TN; Chandra Mangalhara K; Lana A; Yeang C; Han C; Schlachetzki J; Challcombe J; Fixsen BR; Sakai M; Li RZ; Fields H; Mokry M; Tsai RG; Bejar R; Prange K; de Winther M; Shadel GS; Glass CK
Immunity; 2022 Aug; 55(8):1386-1401.e10. PubMed ID: 35931086
[TBL] [Abstract][Full Text] [Related]
26. TET proteins and 5-methylcytosine oxidation in hematological cancers.
Ko M; An J; Pastor WA; Koralov SB; Rajewsky K; Rao A
Immunol Rev; 2015 Jan; 263(1):6-21. PubMed ID: 25510268
[TBL] [Abstract][Full Text] [Related]
27. Clonal Hematopoiesis Is Associated With Higher Risk of Stroke.
Bhattacharya R; Zekavat SM; Haessler J; Fornage M; Raffield L; Uddin MM; Bick AG; Niroula A; Yu B; Gibson C; Griffin G; Morrison AC; Psaty BM; Longstreth WT; Bis JC; Rich SS; Rotter JI; Tracy RP; Correa A; Seshadri S; Johnson A; Collins JM; Hayden KM; Madsen TE; Ballantyne CM; Jaiswal S; Ebert BL; Kooperberg C; Manson JE; Whitsel EA; ; Natarajan P; Reiner AP
Stroke; 2022 Mar; 53(3):788-797. PubMed ID: 34743536
[TBL] [Abstract][Full Text] [Related]
28. Clonal hematopoiesis related TET2 loss-of-function impedes IL1β-mediated epigenetic reprogramming in hematopoietic stem and progenitor cells.
McClatchy J; Strogantsev R; Wolfe E; Lin HY; Mohammadhosseini M; Davis BA; Eden C; Goldman D; Fleming WH; Conley P; Wu G; Cimmino L; Mohammed H; Agarwal A
Nat Commun; 2023 Dec; 14(1):8102. PubMed ID: 38062031
[TBL] [Abstract][Full Text] [Related]
29. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.
Dorsheimer L; Assmus B; Rasper T; Ortmann CA; Ecke A; Abou-El-Ardat K; Schmid T; Brüne B; Wagner S; Serve H; Hoffmann J; Seeger F; Dimmeler S; Zeiher AM; Rieger MA
JAMA Cardiol; 2019 Jan; 4(1):25-33. PubMed ID: 30566180
[TBL] [Abstract][Full Text] [Related]
30. High frequency of clonal hematopoiesis in Erdheim-Chester disease.
Cohen Aubart F; Roos-Weil D; Armand M; Marceau-Renaut A; Emile JF; Duployez N; Charlotte F; Poulain S; Lhote R; Hélias-Rodzewicz Z; Della-Valle V; Bernard O; Maloum K; Nguyen-Khac F; Donadieu J; Amoura Z; Abdel-Wahab O; Haroche J
Blood; 2021 Jan; 137(4):485-492. PubMed ID: 33067622
[TBL] [Abstract][Full Text] [Related]
31. TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis.
Tulstrup M; Soerensen M; Hansen JW; Gillberg L; Needhamsen M; Kaastrup K; Helin K; Christensen K; Weischenfeldt J; Grønbæk K
Nat Commun; 2021 Oct; 12(1):6061. PubMed ID: 34663818
[TBL] [Abstract][Full Text] [Related]
32. Bronchial Epithelial Tet2 Maintains Epithelial Integrity during Acute Pseudomonas aeruginosa Pneumonia.
Qin W; Brands X; Van't Veer C; de Vos AF; Scicluna BP; van der Poll T
Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33046509
[TBL] [Abstract][Full Text] [Related]
33. Cell of origin epigenetic priming determines susceptibility to Tet2 mutation.
Schiroli G; Kartha V; Duarte FM; Kristiansen TA; Mayerhofer C; Shrestha R; Earl A; Hu Y; Tay T; Rhee C; Buenrostro JD; Scadden DT
Nat Commun; 2024 May; 15(1):4325. PubMed ID: 38773071
[TBL] [Abstract][Full Text] [Related]
34. A new risk factor associated with cardiovascular disease: clonal hematopoiesis of indeterminate potential.
Yu X; Qian N; Wang Y
Mol Biol Rep; 2023 Mar; 50(3):2813-2822. PubMed ID: 36595120
[TBL] [Abstract][Full Text] [Related]
35. Tet2 restrains inflammatory gene expression in macrophages.
Cull AH; Snetsinger B; Buckstein R; Wells RA; Rauh MJ
Exp Hematol; 2017 Nov; 55():56-70.e13. PubMed ID: 28826859
[TBL] [Abstract][Full Text] [Related]
36. Clonal haematopoiesis is increased in early onset in systemic sclerosis.
Ricard L; Hirsch P; Largeaud L; Deswarte C; Jachiet V; Mohty M; Rivière S; Malard F; Tenon M; de Vassoigne F; Fain O; Gaugler B; Rossignol J; Delhommeau F; Mekinian A;
Rheumatology (Oxford); 2020 Nov; 59(11):3499-3504. PubMed ID: 32757002
[TBL] [Abstract][Full Text] [Related]
37. Nonpreferential but Detrimental Accumulation of Macrophages With Clonal Hematopoiesis-Driver Mutations in Cardiovascular Tissues-Brief Report.
Dederichs TS; Yerdenova A; Horstmann H; Vico TA; Nübling S; Peyronnet R; Pfeifer D; von Zur Muehlen C; Heidt T; Wolf D; Czerny M; Westermann D; Hilgendorf I
Arterioscler Thromb Vasc Biol; 2024 Mar; 44(3):690-697. PubMed ID: 38269586
[TBL] [Abstract][Full Text] [Related]
38. Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk.
Haring B; Wissel S; Manson JE
Curr Cardiol Rep; 2022 Aug; 24(8):1049-1058. PubMed ID: 35657494
[TBL] [Abstract][Full Text] [Related]
39. TET2-mutant clonal hematopoiesis and risk of gout.
Agrawal M; Niroula A; Cunin P; McConkey M; Shkolnik V; Kim PG; Wong WJ; Weeks LD; Lin AE; Miller PG; Gibson CJ; Sekar A; Schaefer IM; Neuberg D; Stone RM; Bick AG; Uddin MM; Griffin GK; Jaiswal S; Natarajan P; Nigrovic PA; Rao DA; Ebert BL
Blood; 2022 Sep; 140(10):1094-1103. PubMed ID: 35714308
[TBL] [Abstract][Full Text] [Related]
40. Myeloid cell tet methylcytosine dioxygenase 2 does not affect the host response during gram-negative bacterial pneumonia and sepsis.
Qin W; Brands X; van 't Veer C; de Vos AF; Scicluna BP; van der Poll T
Cytokine; 2022 Jun; 154():155876. PubMed ID: 35405484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
